Literature DB >> 27418376

Alzheimer disease: Host immune defence, amyloid-β peptide and Alzheimer disease.

Todd E Golde1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27418376     DOI： 10.1038/nrneurol.2016.105

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  The pathogenesis of Alzheimer's disease and the role of Abeta42.

Authors:  Todd E Golde
Journal:  CNS Spectr       Date:  2007-01       Impact factor: 3.790

2.  The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.

Authors:  Stephanie J Soscia; James E Kirby; Kevin J Washicosky; Stephanie M Tucker; Martin Ingelsson; Bradley Hyman; Mark A Burton; Lee E Goldstein; Scott Duong; Rudolph E Tanzi; Robert D Moir
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

Review 3.  Innate immunity in Alzheimer's disease.

Authors:  Michael T Heneka; Douglas T Golenbock; Eicke Latz
Journal:  Nat Immunol       Date:  2015-03       Impact factor: 25.606

Review 4.  Antimicrobial properties of amyloid peptides.

Authors:  Bruce L Kagan; Hyunbum Jang; Ricardo Capone; Fernando Teran Arce; Srinivasan Ramachandran; Ratnesh Lal; Ruth Nussinov
Journal:  Mol Pharm       Date:  2011-11-29       Impact factor: 4.939

Review 5.  Microbes and Alzheimer's Disease.

Authors:  Ruth F Itzhaki; Richard Lathe; Brian J Balin; Melvyn J Ball; Elaine L Bearer; Heiko Braak; Maria J Bullido; Chris Carter; Mario Clerici; S Louise Cosby; Kelly Del Tredici; Hugh Field; Tamas Fulop; Claudio Grassi; W Sue T Griffin; Jürgen Haas; Alan P Hudson; Angela R Kamer; Douglas B Kell; Federico Licastro; Luc Letenneur; Hugo Lövheim; Roberta Mancuso; Judith Miklossy; Carola Otth; Anna Teresa Palamara; George Perry; Christopher Preston; Etheresia Pretorius; Timo Strandberg; Naji Tabet; Simon D Taylor-Robinson; Judith A Whittum-Hudson
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 6.  Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.

Authors:  Mathias Jucker; Lary C Walker
Journal:  Ann Neurol       Date:  2011-10       Impact factor: 10.422

Review 7.  The secretases: enzymes with therapeutic potential in Alzheimer disease.

Authors:  Bart De Strooper; Robert Vassar; Todd Golde
Journal:  Nat Rev Neurol       Date:  2010-02       Impact factor: 42.937

8.  Alzheimer disease: TREM2 linked to late-onset AD.

Authors:  Bryony Jones
Journal:  Nat Rev Neurol       Date:  2012-12-04       Impact factor: 42.937

9.  Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease.

Authors:  Deepak Kumar Vijaya Kumar; Se Hoon Choi; Kevin J Washicosky; William A Eimer; Stephanie Tucker; Jessica Ghofrani; Aaron Lefkowitz; Gawain McColl; Lee E Goldstein; Rudolph E Tanzi; Robert D Moir
Journal:  Sci Transl Med       Date:  2016-05-25       Impact factor: 17.956

10.  Murine Aβ over-production produces diffuse and compact Alzheimer-type amyloid deposits.

Authors:  Guilian Xu; Yong Ran; Susan E Fromholt; Chunhua Fu; Anthony T Yachnis; Todd E Golde; David R Borchelt
Journal:  Acta Neuropathol Commun       Date:  2015-11-14       Impact factor: 7.801
  10 in total
  12 in total

1.  The lexicon of antimicrobial peptides: a complete set of arginine and tryptophan sequences.

Authors:  Sam Clark; Thomas A Jowitt; Lynda K Harris; Christopher G Knight; Curtis B Dobson
Journal:  Commun Biol       Date:  2021-05-21

2.  Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease.

Authors:  Tamàs Fülöp; Usma Munawara; Anis Larbi; Mathieu Desroches; Serafim Rodrigues; Michele Catanzaro; Andrea Guidolin; Abdelouahed Khalil; François Bernier; Annelise E Barron; Katsuiku Hirokawa; Pascale B Beauregard; David Dumoulin; Jean-Philippe Bellenger; Jacek M Witkowski; Eric Frost
Journal:  CNS Drugs       Date:  2020-07       Impact factor: 6.497

Review 3.  Microbial involvement in Alzheimer disease development and progression.

Authors:  Hannah R Bulgart; Evan W Neczypor; Loren E Wold; Amy R Mackos
Journal:  Mol Neurodegener       Date:  2020-07-24       Impact factor: 14.195

4.  Mitogen-activated protein kinase phosphatase 1 protects PC12 cells from amyloid beta-induced neurotoxicity.

Authors:  Yue Gu; Lian-Jun Ma; Xiao-Xue Bai; Jing Jie; Xiu-Fang Zhang; Dong Chen; Xiao-Ping Li
Journal:  Neural Regen Res       Date:  2018-10       Impact factor: 5.135

5.  Infection-Induced Systemic Inflammation Is a Potential Driver of Alzheimer's Disease Progression.

Authors:  Vijayasree V Giridharan; Faisal Masud; Fabricia Petronilho; Felipe Dal-Pizzol; Tatiana Barichello
Journal:  Front Aging Neurosci       Date:  2019-05-28       Impact factor: 5.750

Review 6.  Warm, Sweetened Milk at the Twilight of Immunity - Alzheimer's Disease - Inflammaging, Insulin Resistance, M. paratuberculosis and Immunosenescence.

Authors:  Coad Thomas Dow
Journal:  Front Immunol       Date:  2021-08-05       Impact factor: 7.561

7.  Physiological clearance of Aβ by spleen and splenectomy aggravates Alzheimer-type pathogenesis.

Authors:  Zhong-Yuan Yu; Dong-Wan Chen; Cheng-Rong Tan; Gui-Hua Zeng; Chen-Yang He; Jun Wang; Xian-Le Bu; Yan-Jiang Wang
Journal:  Aging Cell       Date:  2021-12-23       Impact factor: 9.304

8.  Receptor for Advanced Glycation End Products (RAGE) Mediates Cognitive Impairment Triggered by Pneumococcal Meningitis.

Authors:  Vijayasree V Giridharan; Jaqueline S Generoso; Allan Collodel; Diogo Dominguini; Cristiano Julio Faller; Flavio Tardin; Gursimrat S Bhatti; Fabricia Petronilho; Felipe Dal-Pizzol; Tatiana Barichello
Journal:  Neurotherapeutics       Date:  2021-01       Impact factor: 7.620

9.  Antimicrobial α-defensins as multi-target inhibitors against amyloid formation and microbial infection.

Authors:  Yanxian Zhang; Yonglan Liu; Yijing Tang; Dong Zhang; Huacheng He; Jiang Wu; Jie Zheng
Journal:  Chem Sci       Date:  2021-05-28       Impact factor: 9.825

10.  Potential Virus Involvement in Alzheimer's Disease: Results from a Phase IIa Trial Evaluating Apovir, an Antiviral Drug Combination.

Authors:  Nina Lindblom; Lars Lindquist; Jacob Westman; Mikael Åström; Roger Bullock; Suzanne Hendrix; Lars-Olof Wahlund
Journal:  J Alzheimers Dis Rep       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.